![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/06/05/2893719/15991/en/Amicus-Therapeutics-to-Present-at-the-Goldman-Sachs-45th-Annual-Global-Healthcare-Conference.html
https://www.globenewswire.com/news-release/2024/06/04/2892922/15991/en/Amicus-Therapeutics-Receives-Prix-Galien-U-K-Award-for-Pombiliti-cipaglucosidase-alfa-Opfolda-miglustat-as-Best-Pharmaceutical-Product.html
https://www.globenewswire.com/news-release/2024/05/09/2878602/15991/en/Amicus-Therapeutics-Announces-First-Quarter-2024-Financial-Results-and-Corporate-Updates.html
https://endpts.com/bio-ceo-defends-the-organizations-about-face-on-the-biosecure-act/
https://www.globenewswire.com/news-release/2024/05/08/2877674/15991/en/Amicus-Therapeutics-to-Present-at-the-Bank-of-America-2024-Health-Care-Conference.html
https://www.globenewswire.com/news-release/2024/05/01/2873085/15991/en/Amicus-Therapeutics-to-Announce-First-Quarter-2024-Financial-Results-on-May-9-2024.html
https://www.globenewswire.com/news-release/2024/03/20/2849230/15991/en/Amicus-Therapeutics-Issues-2024-Environmental-Social-and-Governance-ESG-Report.html
https://www.globenewswire.com//news-release/2024/03/01/2838732/15991/en/Amicus-Therapeutics-to-Present-at-Upcoming-Investor-Conferences-in-March-2024.html
https://www.globenewswire.com//news-release/2024/02/28/2836812/15991/en/Amicus-Therapeutics-Announces-Full-Year-2023-Financial-Results-and-Corporate-Updates.html
https://www.globenewswire.com//news-release/2024/02/15/2829804/15991/en/Amicus-Therapeutics-to-Announce-Full-Year-2023-Financial-Results-on-February-28-2024.html